Immunological and virological benefits resulted from short-course treatment during primary HIV infection: a meta-analysis.

<h4>Objectives</h4>To assess the potential immunological and virological effects that result from short-course antiretroviral treatment during primary HIV infection (PHI). And to investigate whether treatment initiation time, treatment duration and follow-up time after treatment interrup...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jingjing Chen, Xiaoxu Han, Minghui An, Jing Liu, Junjie Xu, Wenqing Geng, Yangtao Ji, Hong Shang
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2013
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/5a2d4bd59b7a4a3698c4833697c641db
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5a2d4bd59b7a4a3698c4833697c641db
record_format	dspace
spelling	oai:doaj.org-article:5a2d4bd59b7a4a3698c4833697c641db2021-11-18T08:43:05ZImmunological and virological benefits resulted from short-course treatment during primary HIV infection: a meta-analysis.1932-620310.1371/journal.pone.0082461https://doaj.org/article/5a2d4bd59b7a4a3698c4833697c641db2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24324793/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Objectives</h4>To assess the potential immunological and virological effects that result from short-course antiretroviral treatment during primary HIV infection (PHI). And to investigate whether treatment initiation time, treatment duration and follow-up time after treatment interruption would affect these post-treatment immunovirological outcomes.<h4>Methods</h4>We systematically searched PubMed, Cochrane Library (to September 2013) and retrieved conference abstracts for studies regarding effects of early treatment during PHI on CD4 count and viral load (VL). Using the method of calculating weighted mean differences with Stata11.0, we conducted meta-analyses on the effect of early treatment on CD4 count and VL. Then we performed subgroup analyses by follow-up time after treatment interruption, treatment initiation time and treatment duration. Baseline immunovirological characteristics were also analyzed to account for potential bias.<h4>Results</h4>Compared to the untreated arm, treatment during PHI not only increased CD4 count by 85.92 cells/μl but also lowered viral load by 0.30 log copies/ml within one year after treatment interruption. However, the benefits declined gradually, reaching no significance 12-24 months after treatment interruption. Baseline immunovirological characteristics and sensitivity analyses of randomized controlled trials indicated that the benefits mentioned above were underestimated. Extending treatment duration beyond 12 months did not increase efficacy.<h4>Conclusions</h4>Short-course treatment during PHI was associated with immunological and virological benefits which last for at least one year after treatment interruption. The conclusions from our study would help the decision-making in the clinical management of PHI.Jingjing ChenXiaoxu HanMinghui AnJing LiuJunjie XuWenqing GengYangtao JiHong ShangPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 12, p e82461 (2013)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Jingjing Chen Xiaoxu Han Minghui An Jing Liu Junjie Xu Wenqing Geng Yangtao Ji Hong Shang Immunological and virological benefits resulted from short-course treatment during primary HIV infection: a meta-analysis.
description	<h4>Objectives</h4>To assess the potential immunological and virological effects that result from short-course antiretroviral treatment during primary HIV infection (PHI). And to investigate whether treatment initiation time, treatment duration and follow-up time after treatment interruption would affect these post-treatment immunovirological outcomes.<h4>Methods</h4>We systematically searched PubMed, Cochrane Library (to September 2013) and retrieved conference abstracts for studies regarding effects of early treatment during PHI on CD4 count and viral load (VL). Using the method of calculating weighted mean differences with Stata11.0, we conducted meta-analyses on the effect of early treatment on CD4 count and VL. Then we performed subgroup analyses by follow-up time after treatment interruption, treatment initiation time and treatment duration. Baseline immunovirological characteristics were also analyzed to account for potential bias.<h4>Results</h4>Compared to the untreated arm, treatment during PHI not only increased CD4 count by 85.92 cells/μl but also lowered viral load by 0.30 log copies/ml within one year after treatment interruption. However, the benefits declined gradually, reaching no significance 12-24 months after treatment interruption. Baseline immunovirological characteristics and sensitivity analyses of randomized controlled trials indicated that the benefits mentioned above were underestimated. Extending treatment duration beyond 12 months did not increase efficacy.<h4>Conclusions</h4>Short-course treatment during PHI was associated with immunological and virological benefits which last for at least one year after treatment interruption. The conclusions from our study would help the decision-making in the clinical management of PHI.
format	article
author	Jingjing Chen Xiaoxu Han Minghui An Jing Liu Junjie Xu Wenqing Geng Yangtao Ji Hong Shang
author_facet	Jingjing Chen Xiaoxu Han Minghui An Jing Liu Junjie Xu Wenqing Geng Yangtao Ji Hong Shang
author_sort	Jingjing Chen
title	Immunological and virological benefits resulted from short-course treatment during primary HIV infection: a meta-analysis.
title_short	Immunological and virological benefits resulted from short-course treatment during primary HIV infection: a meta-analysis.
title_full	Immunological and virological benefits resulted from short-course treatment during primary HIV infection: a meta-analysis.
title_fullStr	Immunological and virological benefits resulted from short-course treatment during primary HIV infection: a meta-analysis.
title_full_unstemmed	Immunological and virological benefits resulted from short-course treatment during primary HIV infection: a meta-analysis.
title_sort	immunological and virological benefits resulted from short-course treatment during primary hiv infection: a meta-analysis.
publisher	Public Library of Science (PLoS)
publishDate	2013
url	https://doaj.org/article/5a2d4bd59b7a4a3698c4833697c641db
work_keys_str_mv	AT jingjingchen immunologicalandvirologicalbenefitsresultedfromshortcoursetreatmentduringprimaryhivinfectionametaanalysis AT xiaoxuhan immunologicalandvirologicalbenefitsresultedfromshortcoursetreatmentduringprimaryhivinfectionametaanalysis AT minghuian immunologicalandvirologicalbenefitsresultedfromshortcoursetreatmentduringprimaryhivinfectionametaanalysis AT jingliu immunologicalandvirologicalbenefitsresultedfromshortcoursetreatmentduringprimaryhivinfectionametaanalysis AT junjiexu immunologicalandvirologicalbenefitsresultedfromshortcoursetreatmentduringprimaryhivinfectionametaanalysis AT wenqinggeng immunologicalandvirologicalbenefitsresultedfromshortcoursetreatmentduringprimaryhivinfectionametaanalysis AT yangtaoji immunologicalandvirologicalbenefitsresultedfromshortcoursetreatmentduringprimaryhivinfectionametaanalysis AT hongshang immunologicalandvirologicalbenefitsresultedfromshortcoursetreatmentduringprimaryhivinfectionametaanalysis
_version_	1718421384833531904

Immunological and virological benefits resulted from short-course treatment during primary HIV infection: a meta-analysis.

Ejemplares similares